Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-29 @ 6:23 PM
Study NCT ID:
NCT01886820
Status:
UNKNOWN
Last Update Posted:
2017-07-26
First Post:
2013-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Sponsor:
Navidea Biopharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-09
Completion Date Type:
ESTIMATED
First Submit Date:
2013-06-24
First Submit QC Date:
None
Study First Post Date:
2013-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-25
Last Update Post Date:
2017-07-26
Last Update Post Date Type:
ACTUAL